BamSEC and AlphaSense Join Forces
Learn More

Imvision Therapeutics Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.23
from POS AM 4 pages Amendment to Restricted Stock Purchase Agreement
12/34/56
EX-10.22
from POS AM 3 pages Imvision Therapeutics Inc. Feodor-Lynen Strasse 5, Hanover, Germany Tel: 011 49 511 53 88 96-76 Fax: 011 49 511 53 88 96-66
12/34/56
EX-10.21
from SB-2/A 3 pages Rcc Linking Science to Progress
12/34/56
EX-10.20
from SB-2/A 1 page Imvision Therapeutics Inc. Feodor-Lynen Strasse 5, Hanover, Germany Tel: 011 49 511 53 88 96-76 Fax: 011 49 511 53 88 96-66
12/34/56
EX-10.19
from SB-2/A 4 pages Seite 2 Attachment A1
12/34/56
EX-10.18
from SB-2/A 7 pages Consultancy Agreement
12/34/56
EX-10.17
from SB-2/A 5 pages Consultancy Agreement
12/34/56
EX-10.16
from SB-2/A 14 pages Collaboration Agreement Development of a Proof-Of-Concept Formulation of Ivn201 Between Imvision Gmbh, Feodor Lynen Strasse 5, D-30625 Hannover, Germany (“Imvision”) and Therapeomic Inc., Biozentrum, University of Basel, Klingenbergstrasse 70, Ch-4056 Basel, Switzerland
12/34/56
EX-10.8
from SB-2/A 4 pages Service Agreement
12/34/56
EX-10.15
from SB-2 1 page Amendment to Employment Agreement
12/34/56
EX-10.14
from SB-2 1 page Amendment to Employment Agreement
12/34/56
EX-10.13
from SB-2 9 pages Regulation S Subscription Agreement
12/34/56
EX-10.12
from SB-2 3 pages Restricted Stock Purchase Agreement
12/34/56
EX-10.11
from SB-2 5 pages Subscription Agreement Imvision Therapeutics Inc
12/34/56
EX-10.10
from SB-2 3 pages Debondo Capital Limited 27 New Bond Street, London, W1s 2rh, United Kingdom Telephone: +44 7970 712 964, Facimile: +44 20 7031 1199 Company Reg: 5666674, Managing Director: Ulrik Debo
12/34/56
EX-10.9
from SB-2 20 pages Exclusive License Agreement
12/34/56
EX-10.8
from SB-2 4 pages Service Agreement
12/34/56
EX-10.7
from SB-2 18 pages Agreement Strain Development, Process Development and Manufacturing of Clinical Grade Material of a Fel D1 Mat Fusion Protein Between Imvision Gmbh, Feodor Lynen Strasse 5, Hannover (Ivn) and Strathmann Biotec AG, Habichthorst 30, 22459 Hamburg, Germany (Sbag) 1 Preamble Imvision Gmbh Is a Biotechnology Company Based in Hannover, Germany, and Focused on the Development of Novel Immuntherapies Based on Its Mat (Modular-Antigen-Transporter) Technology Platform to Treat Allergic Diseases, (Chronic) Infectious Diseases and Possibly Cancer
12/34/56
EX-10.6
from SB-2 17 pages M a S T E R S E R V I C E S a G R E E M E N T
12/34/56
EX-10.5
from SB-2 7 pages Patent Purchasing Agreement and Backlicense Agreement Between Productomics AG, Promenade 132 A, Ch-7260 Davos-Dorf, Switzerland
12/34/56